DDOG
Datadog, Inc.
DDOG has the edge over NVO overall, supported by stronger fundamentals and stronger valuation.
NVO
Novo Nordisk A/S
NVO trails on the overall score without a compensating advantage in the available component scores.
DDOG Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
DDOG's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DDOG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 62x | $184 | — |
| Cheap | 251x | $181 | -2.1% |
| Current | 256x | $184 | — |
| Fair | 379x | $273 | +48% |
| Expensive | 621x | $447 | +142% |
Historical ranges are pointers, not guarantees.
DDOG's PE is in its cheap range at 256x. If earnings grow as analysts expect, today's price would be 62x next year's earnings.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over DDOG in the historical PE scenario, which offers more potential upside but is not a forecast.
DDOG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Broad | |
| Low |
DDOG has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
DDOG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.99 | +315% |
| Q3 2026 | $0.72 | +125% |
| Q2 2026 | $0.50 | +39% |
| Q1 2026 | $0.39 | -17% |
| Q4 2025 | $0.31 | -40% |
| Q3 2025 | $0.32 | -42% |
| Q2 2025 | $0.36 | -23% |
| Q1 2025 | $0.47 | +38% |
| Q4 2024 | $0.52 | +271% |
DDOG earned $0.72 per share over the past year, up 125% from the year before.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over DDOG on earnings, with more consistent year-over-year improvement.
DDOG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +35% |
| Q2 2026 | $1.1B | +36% |
| Q1 2026 | $1B | +32% |
| Q4 2025 | $953.2M | +29% |
| Q3 2025 | $885.7M | +28% |
| Q2 2025 | $826.8M | +28% |
| Q1 2025 | $761.6M | +25% |
| Q4 2024 | $737.7M | +25% |
DDOG has the edge over NVO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | +6.9 points |
| Q2 2026 | 0.5% | +4.8 points |
| Q1 2026 | 0.7% | +2.4 points |
| Q4 2025 | 1% | -0.3 points |
| Q3 2025 | -0.7% | -3.6 points |
| Q2 2025 | -4.3% | -6.3 points |
| Q1 2025 | -1.6% | -3.6 points |
| Q4 2024 | 1.3% | -3.4 points |
DDOG's operating margin was 6.2% last quarter, up 6.9 points from the same quarter a year ago, near the top of its range since 2019.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over DDOG on profitability, with a higher operating margin.
DDOG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $279.1M | +19% |
| Q2 2026 | $306M | +65% |
| Q1 2026 | $323.3M | +23% |
| Q4 2025 | $318.2M | +24% |
| Q3 2025 | $234.7M | +6.5% |
| Q2 2025 | $184.9M | +16% |
| Q1 2025 | $262.8M | +33% |
| Q4 2024 | $257.5M | +23% |
DDOG has the edge over NVO on cash flow, with more consistent year-over-year improvement.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
DDOG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +4M shares |
| 1 year | +3.6% | +13M shares |
| 3 years | +6.7% | +23.7M shares |
| 5 years | +21% | +64.8M shares |
| Available history | +14% | +47.2M shares |
DDOG has 375M diluted shares, up 3.6% from a year ago.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over DDOG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
DDOG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 7.0x | High |
| Q1 2026 | 18.2x | High |
| Q4 2025 | 123.2x | High |
| Q3 2025 | 94.8x | High |
| Q2 2025 | 16.5x | High |
| Q1 2025 | 6.9x | High |
| Q4 2024 | 3.6x | Elevated |
DDOG's net debt is less than a year of its operating earnings (EBITDA), down from more than 20 years a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO has the edge over DDOG on leverage, with a lower net debt burden relative to earnings.
DDOG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.7 | Oversold |
DDOG's weekly RSI is 43 (neutral) and its Stochastic is 17 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
DDOG PE vs Technology Sector
| Metric | DDOG | Sector median | Relative |
|---|---|---|---|
| PE | 256x | 28x | 820% above |
| PE % | 19 | 35 | 16 pts below |
DDOG is trading at 256x earnings, a 820% premium to the Technology sector's median of 28x.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over DDOG on valuation relative to its sector.
DDOG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $244.3 | 24% below |
| 20 week MA | $243.6 | 24% below |
| 50 week MA | $189.3 | 2.6% below |
| 100 week MA | $161.1 | 14% above |
| 200 week MA | $134.5 | 37% above |
DDOG has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
DDOG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.1 | $106.3 | +194% |
| 2021 | $106.3 | $180.4 | +70% |
| 2022 | $180.4 | $72.4 | -60% |
| 2023 | $72.4 | $121.4 | +68% |
| 2024 | $121.4 | $146.0 | +20% |
| 2025 | $146.0 | $138.3 | -5.3% |
| 2026 YTD | $138.3 | $184.5 | +33% |
DDOG has the edge over NVO on returns for 2026, with the stronger performance.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.